Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von SERVIER
EUROPA-Studie (Perindopril) (60 Abbildungen)
Übersicht
Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)


Zum ersten Bild Abb. 53: EUROPA-Studie - Interaktionsanalyse Abb. 54: EUROPA-Studie - Benefits Abb. 55: EUROPA-Studie - HOPE-Studie Abb. 56: EUROPA-Studie - HOPE-Studie Abb. 57: EUROPA-Studie - HOPE-Studie Abb. 58: EUROPA-Studie - Ergebnisse Abb. 59: EUROPA-Studie - Benefit Aktuelles Bild - Abb. 60: EUROPA-Studie - Ergebnisse
Abbildung 60: EUROPA-Studie - Ergebnisse
Last but not least, all these benefits demonstrated with perindopril 8 mg once daily in EUROPA trial, were achieved on top of standard optimal treatment (platelet inhibitors, lipid lowering drugs and ß -blockers) and are consistent in all sub-groups of patients. Perindopril should be used in chronic therapy in all patients with coronary disease: As prof. Willem Remme concluded: "We now have sufficient evidence to show that perindopril, due to its anti-atherogenic effects and blood pressure lowering properties is beneficial and should be used in treating all patients with coronary artery disease".
 
EUROPA-Studie - Ergebnisse
Vorheriges Bild Nächstes Bild  


Abbildung 60: EUROPA-Studie - Ergebnisse
Last but not least, all these benefits demonstrated with perindopril 8 mg once daily in EUROPA trial, were achieved on top of standard optimal treatment (platelet inhibitors, lipid lowering drugs and ß -blockers) and are consistent in all sub-groups of patients. Perindopril should be used in chronic therapy in all patients with coronary disease: As prof. Willem Remme concluded: "We now have sufficient evidence to show that perindopril, due to its anti-atherogenic effects and blood pressure lowering properties is beneficial and should be used in treating all patients with coronary artery disease".
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung